INNOVO by Atlantic Therapeutics

Name

INNOVO by Atlantic Therapeutics

Website

https://atlantictherapeutics.com

Company type

Private

Founded year

2013

Operating status

Acquired

Headcount range

11–50 employees

Short description

Atlantic Therapeutics, trading as INNOVO, is a Galway, Ireland-based medical device company that develops the Innovo neuromuscular electrical stimulation device for non-invasive treatment of female stress urinary incontinence and pelvic floor disorders. Now operates as a subsidiary of Caldera Medical following its September 2023 acquisition.

Ownership category

akta.pro rank

Product category

Pelvic Floor Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH)

Keywords

• Pelvic floor therapy
• Neuromuscular electrical stimulation
• Incontinence treatment device
• Women's health medical device
• Non-invasive pelvic rehabilitation

Headquarters

HQ city

Galway

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Medical Device Sales: Atlantic Therapeutics generates revenue through the sale of its neuromuscular electrical stimulation medical devices, including the Innovo product line, which are used for non-invasive treatment of incontinence and sexual health dysfunctions.

Go-to-market motion1 record

Core offering

INNOVO by Atlantic Therapeutics develops and commercializes the Innovo neuromuscular electrical stimulation device, a wearable medical device that delivers targeted electrical stimulation to the pelvic floor muscles for the non-invasive treatment of stress urinary incontinence and sexual health dysfunctions. The product is positioned as a clinical, home-based alternative to invasive surgery and pharmacological therapy for pelvic floor disorders.

Differentiator

Problem solved

Functional benefit

Brands

• Innovo: Neuromuscular electrical stimulation device used to treat conditions such as incontinence and sexual health dysfunctions.

Quantifiable outcome

• Non-invasive treatment option for pelvic floor disorders

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Broad incumbents

• Caldera Medical: Caldera Medical is the strategic acquirer of Atlantic Therapeutics and a women's pelvic health medical device company focused on surgical solutions for stress urinary incontinence and pelvic organ prolapse. It is now the parent entity, making its portfolio directly comparable in target market and indication.
• Coloplast: Coloplast is a global incumbent in continence care, offering a broad portfolio of catheters, incontinence products, and pelvic health solutions. It competes broadly with Innovo for the same patient population through alternative continence management approaches.
• Hologic: Hologic is a large women's health diagnostics and medical device company with a portfolio spanning mammography, gynecologic surgical solutions, and pelvic health. It is a broad incumbent with overlapping patient/provider channels relevant to Innovo's target market.
• Cogentix Medical (now part of Laborie): Cogentix Medical offered minimally invasive urology and continence care products (e.g., Urgent PC, PTQ implants) and has been integrated into Laborie. It is a broad incumbent peer with overlapping focus on neuromodulation and incontinence treatment.
• Laborie Medical Technologies: Laborie is a large established player in urology and pelvic health diagnostics and therapeutics, including urodynamics and incontinence care. It is a broad incumbent competitor whose portfolio overlaps with Innovo's clinical use case across pelvic floor disorders.

Emerging players

• Viveve Medical: Viveve develops energy-based women's health devices addressing vaginal laxity, stress urinary incontinence, and sexual function. It overlaps with Innovo's clinical use case in non-invasive SUI treatment using a different (radiofrequency) modality.

Direct peers

• TensCare: TensCare manufactures TENS/EMS electrotherapy devices, including pelvic floor stimulators for incontinence. It is a direct comparable in the NMES/electrotherapeutic incontinence device category with overlapping product architecture.
• InControl Medical: InControl Medical manufactures FDA-cleared neuromuscular stimulation devices for urinary and fecal incontinence (e.g., Attain, InTone). It is a direct clinical peer to Innovo in the NMES-based incontinence treatment category.
• Elvie (Chiaro Technology): Elvie develops connected pelvic floor trainers and women's health hardware (Elvie Trainer, Elvie Pump). It competes directly with Innovo in the consumer-grade pelvic floor strengthening category, targeting the same women with stress urinary incontinence through a DTC, app-connected approach.
• Perifit: Perifit offers connected biofeedback pelvic floor trainers with app-based exercise programs for treating urinary incontinence. It is a direct competitor to Innovo in the at-home, app-paired pelvic floor therapy category.

Market position

Customer concentration

• LinkedInlinkedin.com/company/atlantic-therapeutics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INNOVO by Atlantic Therapeutics